{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:14:08Z","timestamp":1784265248790,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03070-5","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T05:01:45Z","timestamp":1716872505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Contraceptive counseling for iPLEDGE and its burden on dermatologists"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9487-1649","authenticated-orcid":false,"given":"Kelly E.","family":"Owens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9509-9001","authenticated-orcid":false,"given":"Simon W.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda W.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"11","key":"3070_CR1","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1371\/journal.pmed.0030483","volume":"3","author":"L Abroms","year":"2006","unstructured":"Abroms L et al (2006) What is the best approach to reducing birth defects associated with isotretinoin? PLoS Med 3(11):e483. https:\/\/doi.org\/10.1371\/journal.pmed.0030483","journal-title":"PLoS Med"},{"issue":"2","key":"3070_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jaad.2011.04.006","volume":"65","author":"ME Maloney","year":"2011","unstructured":"Maloney ME, Stone SP (2011) Isotretinoin and iPledge: a view of results. J Am Acad Dermatol 65(2):418\u2013419. https:\/\/doi.org\/10.1016\/j.jaad.2011.04.006","journal-title":"J Am Acad Dermatol"},{"key":"3070_CR3","unstructured":"iPLEDGE (2021) iPLEDGE REMS Prescriber Guide : p. 26"},{"key":"3070_CR4","unstructured":"iPLEDGE (2021) iPLEDGE REMS Guide for Patients Who Can Get Pregnant : p. 14"},{"issue":"6","key":"3070_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jaad.2010.09.017","volume":"65","author":"J Shin","year":"2011","unstructured":"Shin J et al (2011) The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. J Am Acad Dermatol 65(6):1117\u20131125. https:\/\/doi.org\/10.1016\/j.jaad.2010.09.017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3070_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jaad.2006.05.018","volume":"55","author":"TC Cheetham","year":"2006","unstructured":"Cheetham TC et al (2006) A risk management program aimed at preventing fetal exposure to isotretinoin: retrospective cohort study. J Am Acad Dermatol 55(3):442\u2013448. https:\/\/doi.org\/10.1016\/j.jaad.2006.05.018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3070_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/jamadermatol.2013.6862","volume":"150","author":"CA Werner","year":"2014","unstructured":"Werner CA et al (2014) Women\u2019s experiences with isotretinoin risk reduction counseling. JAMA Dermatol 150(4):366\u2013371. https:\/\/doi.org\/10.1001\/jamadermatol.2013.6862","journal-title":"JAMA Dermatol"},{"issue":"1","key":"3070_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaad.2013.08.034","volume":"70","author":"MK Collins","year":"2014","unstructured":"Collins MK et al (2014) Compliance with pregnancy prevention measures during isotretinoin therapy. J Am Acad Dermatol 70(1):55\u201359. https:\/\/doi.org\/10.1016\/j.jaad.2013.08.034","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"3070_CR9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/ijd.13950","volume":"57","author":"T Kovitwanichkanont","year":"2018","unstructured":"Kovitwanichkanont T, Driscoll T (2018) A comparative review of the isotretinoin pregnancy risk management programs across four continents. Int J Dermatol 57(9):1035\u20131046. https:\/\/doi.org\/10.1111\/ijd.13950","journal-title":"Int J Dermatol"},{"issue":"10","key":"3070_CR10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1503\/cmaj.151243","volume":"188","author":"D Henry","year":"2016","unstructured":"Henry D et al (2016) Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy. CMAJ 188(10):723\u2013730. https:\/\/doi.org\/10.1503\/cmaj.151243","journal-title":"CMAJ"},{"key":"3070_CR11","unstructured":"BRIEFING DOCUMENT FOR iPLEDGE YEAR ONE UPDATE, in DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEE 2007. p. 45"},{"key":"3070_CR12","unstructured":"Risk Evaluation and Mitigation Strategy (REMS) for Isotretinoin Products iPLEDGE REMS, in Combined Meeting of the Drug Safety and Risk Management Advisory Committee and Dermatologic and Ophthalmic Drugs Advisory Committee. (2023) p. 57"},{"issue":"3","key":"3070_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaad.2019.07.066","volume":"85","author":"P Macklis","year":"2021","unstructured":"Macklis P et al (2021) Factors influencing patients\u2019 choice of contraceptives when starting isotretinoin. J Am Acad Dermatol 85(3):737\u2013738. https:\/\/doi.org\/10.1016\/j.jaad.2019.07.066","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3070_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.7326\/0003-4819-147-6-200709180-00006","volume":"147","author":"EB Schwarz","year":"2007","unstructured":"Schwarz EB et al (2007) Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women. Ann Intern Med 147(6):370\u2013376. https:\/\/doi.org\/10.7326\/0003-4819-147-6-200709180-00006","journal-title":"Ann Intern Med"},{"issue":"1","key":"3070_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2125.2008.03235.x","volume":"67","author":"AI Kanelleas","year":"2009","unstructured":"Kanelleas AI, Thornton S, Berth-Jones J (2009) Suggestions for effective contraception in isotretinoin therapy. Br J Clin Pharmacol 67(1):137\u2013138. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03235.x","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3070_CR16","first-page":"54","volume":"13","author":"K Lowery","year":"2020","unstructured":"Lowery K, Rosen T, Malek J (2020) iPLEDGE must abstain from abstinence. J Clin Aesthet Dermatol 13(6):54\u201356","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"3070_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40264-021-01053-3","volume":"44","author":"Y Albogami","year":"2021","unstructured":"Albogami Y et al (2021) Real-world fetal exposure to Acne treatments in the United States: a retrospective analysis from 2006 to 2015. Drug Saf 44(4):447\u2013454. https:\/\/doi.org\/10.1007\/s40264-021-01053-3","journal-title":"Drug Saf"},{"issue":"1","key":"3070_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamadermatol.2019.3270","volume":"156","author":"JS Barbieri","year":"2020","unstructured":"Barbieri JS, Frieden IJ, Nagler AR (2020) Isotretinoin, Patient Safety, and patient-centered care-time to Reform iPLEDGE. JAMA Dermatol 156(1):21\u201322. https:\/\/doi.org\/10.1001\/jamadermatol.2019.3270","journal-title":"JAMA Dermatol"},{"key":"3070_CR19","unstructured":"Daniels Ka, Abma JC (2015) and S. National Center for Health, Current contraceptive status among women aged 15\u201349: United States, NCHS data brief no. 327. 2018, Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics"},{"issue":"4","key":"3070_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/jamadermatol.2014.4171","volume":"151","author":"CA Werner","year":"2015","unstructured":"Werner CA et al (2015) Promoting safe use of isotretinoin by increasing contraceptive knowledge. JAMA Dermatol 151(4):389\u2013393. https:\/\/doi.org\/10.1001\/jamadermatol.2014.4171","journal-title":"JAMA Dermatol"},{"issue":"1","key":"3070_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/AOG.0000000000005027","volume":"141","author":"J Wu","year":"2023","unstructured":"Wu J et al (2023) TikTok, #IUD, and user experience with Intrauterine devices reported on Social Media. Obstet Gynecol 141(1):215\u2013217. https:\/\/doi.org\/10.1097\/AOG.0000000000005027","journal-title":"Obstet Gynecol"},{"issue":"5","key":"3070_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/pde.15086","volume":"39","author":"CE Smiley","year":"2022","unstructured":"Smiley CE, Butt M, Zaenglein AL (2022) Emergency contraception in the iPLEDGE program: a cross-sectional survey of pediatric dermatology provider understanding and practice. Pediatr Dermatol 39(5):727\u2013730. https:\/\/doi.org\/10.1111\/pde.15086","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"3070_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/bdra.20197","volume":"73","author":"J Robertson","year":"2005","unstructured":"Robertson J et al (2005) A survey of pregnant women using isotretinoin. Birth Defects Res Clin Mol Teratol 73(11):881\u2013887. https:\/\/doi.org\/10.1002\/bdra.20197","journal-title":"Birth Defects Res Clin Mol Teratol"},{"issue":"1","key":"3070_CR24","doi-asserted-by":"publisher","first-page":"p78e1","DOI":"10.1016\/j.ajog.2016.01.173","volume":"215","author":"C Dehlendorf","year":"2016","unstructured":"Dehlendorf C et al (2016) Association of the quality of interpersonal care during family planning counseling with contraceptive use. Am J Obstet Gynecol 215(1):p78e1\u2013p78e9. https:\/\/doi.org\/10.1016\/j.ajog.2016.01.173","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"3070_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.contraception.2012.10.012","volume":"88","author":"C Dehlendorf","year":"2013","unstructured":"Dehlendorf C et al (2013) Women\u2019s preferences for contraceptive counseling and decision making. Contraception 88(2):250\u2013256. https:\/\/doi.org\/10.1016\/j.contraception.2012.10.012","journal-title":"Contraception"},{"issue":"3","key":"3070_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/AOG.0000000000001047","volume":"126","author":"AC Gynecologists","year":"2015","unstructured":"Gynecologists AC (2015) .o.O.a., Practice Bulletin 152: emergency contraception. Obstet Gynecol 126(3):e1\u2013e. https:\/\/doi.org\/10.1097\/AOG.0000000000001047","journal-title":"Obstet Gynecol"},{"issue":"5","key":"3070_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.contraception.2016.12.010","volume":"95","author":"C Dehlendorf","year":"2017","unstructured":"Dehlendorf C et al (2017) Shared decision making in contraceptive counseling. Contraception 95(5):452\u2013455. https:\/\/doi.org\/10.1016\/j.contraception.2016.12.010","journal-title":"Contraception"},{"issue":"1","key":"3070_CR28","doi-asserted-by":"publisher","first-page":"46e1","DOI":"10.1016\/j.ajog.2015.01.051","volume":"213","author":"T Madden","year":"2015","unstructured":"Madden T et al (2015) The role of contraceptive attributes in women\u2019s contraceptive decision making. Am J Obstet Gynecol 213(1):46e1\u201346e6. https:\/\/doi.org\/10.1016\/j.ajog.2015.01.051","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3070_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1363\/46e1814","volume":"46","author":"N Anderson","year":"2014","unstructured":"Anderson N et al (2014) Women\u2019s social communication about IUDs: a qualitative analysis. Perspect Sex Reprod Health 46(3):141\u2013148. https:\/\/doi.org\/10.1363\/46e1814","journal-title":"Perspect Sex Reprod Health"},{"issue":"4","key":"3070_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/GRF.0000000000000070","volume":"57","author":"C McNicholas","year":"2014","unstructured":"McNicholas C et al (2014) The contraceptive CHOICE project round up: what we did and what we learned. Clin Obstet Gynecol 57(4):635\u2013643. https:\/\/doi.org\/10.1097\/GRF.0000000000000070","journal-title":"Clin Obstet Gynecol"},{"issue":"5","key":"3070_CR31","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jaad.2021.04.062","volume":"86","author":"N Shah","year":"2022","unstructured":"Shah N et al (2022) The administrative burden of prescribing and treating with isotretinoin. J Am Acad Dermatol 86(5):1165\u20131167. https:\/\/doi.org\/10.1016\/j.jaad.2021.04.062","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3070_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.12788\/cutis.0558","volume":"110","author":"G Lee","year":"2022","unstructured":"Lee G, Wolf JR, Somers KE (2022) Administrative burden of iPLEDGE deters Isotretinoin prescriptions: results from a survey of dermatologists. Cutis 110(1):44\u201347. https:\/\/doi.org\/10.12788\/cutis.0558","journal-title":"Cutis"},{"issue":"3","key":"3070_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00403-022-02394-4","volume":"315","author":"GY Duan","year":"2023","unstructured":"Duan GY, Ruiz de AM, Luzuriaga (2023) Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center. Arch Dermatol Res 315(3):643\u2013645. https:\/\/doi.org\/10.1007\/s00403-022-02394-4","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"3070_CR34","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jaad.2020.06.039","volume":"84","author":"T Greywal","year":"2021","unstructured":"Greywal T, Eichenfield LF, Marsch A (2021) Isotretinoin and iPledge Program patient information video: a new modality that improves patient comprehension. J Am Acad Dermatol 84(5):1425\u20131426. https:\/\/doi.org\/10.1016\/j.jaad.2020.06.039","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3070_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaad.2020.02.022","volume":"83","author":"JS Barbieri","year":"2020","unstructured":"Barbieri JS, Roe AH, Mostaghimi A (2020) Simplifying contraception requirements for iPLEDGE: a decision analysis. J Am Acad Dermatol 83(1):104\u2013108. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.022","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3070_CR36","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jaad.2008.06.037","volume":"59","author":"AB Kimball","year":"2008","unstructured":"Kimball AB, Resneck JS Jr. (2008) The US dermatology workforce: a specialty remains in shortage. J Am Acad Dermatol 59(5):741\u2013745. https:\/\/doi.org\/10.1016\/j.jaad.2008.06.037","journal-title":"J Am Acad Dermatol"},{"key":"3070_CR37","unstructured":"Association AAoD (2023) AADA PRESSURE ON FDA RESULTS IN IPLEDGE WINS, in AAD\/A Impact Report"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03070-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:38:22Z","timestamp":1719401902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03070-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3070"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03070-5","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"7 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}